1,148
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia

ORCID Icon, , , , ORCID Icon &
Pages 2910-2913 | Received 10 Mar 2019, Accepted 24 May 2019, Published online: 09 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Kevin Y. Wang, Pratik Shah, Brandon Skavla, Fatima Fayyaz, Jeffrey Chi & Joanna M. Rhodes. (2023) Vaccination efficacy in patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 64:1, pages 42-56.
Read now
Оlga L. Kochneva, Maria Kislova, Evgenya I. Zhelnova, Andrei A. Petrenko, Elena A. Baryakh, Konstantin V. Yatskov, Elena A. Dmitrieva, Elena N. Misurina, Konstantin E. Nikitin, Elena J. Vasilieva, Inna V. Samsonova, Vadim V. Ptushkin, Ancha Baranova & Eugene A. Nikitin. (2022) COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study. Leukemia & Lymphoma 63:7, pages 1607-1616.
Read now
Siyue Jia, Jingxin Li, Yuanbao Liu & Fengcai Zhu. (2020) Precision immunization: a new trend in human vaccination. Human Vaccines & Immunotherapeutics 16:3, pages 513-522.
Read now

Articles from other publishers (10)

Sabine Haggenburg, Hannah M. Garcia Garrido, Iris M. J. Kant, Hanneke M. Van der Straaten, Fransien De Boer, Sabina Kersting, Djamila Issa, Doreen Te Raa, Hein P. J. Visser, Arnon P. Kater, Abraham Goorhuis & Koen De Heer. (2023) Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia. Vaccines 11:7, pages 1201.
Crossref
Magdalena Kättström, Bertil Uggla, Elisabet Tina, Eva Kimby, Torbjörn Norén & Simon Athlin. (2023) Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia. Vaccine 41:19, pages 3128-3136.
Crossref
Iwona Hus, Agnieszka Szymczyk, Joanna Mańko & Joanna Drozd-Sokołowska. (2023) COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic. Biology 12:4, pages 545.
Crossref
Per Ljungman. 2023. Plotkin's Vaccines. Plotkin's Vaccines 1432 1449.e11 .
Marta Morawska. (2021) Reasons and consequences of COVID‐19 vaccine failure in patients with chronic lymphocytic leukemia. European Journal of Haematology 108:2, pages 91-98.
Crossref
Simon Galmiche, Liem Binh Luong Nguyen, Eric Tartour, Xavier de Lamballerie, Linda Wittkop, Paul Loubet & Odile Launay. (2022) Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clinical Microbiology and Infection 28:2, pages 163-177.
Crossref
Hamza Hassan, Mohammad Ammad Ud Din, Saad Jamshed, Jonathan Bress & S Shahzad Mustafa. (2021) Effect of ibrutinib on humoral dysfunction in patients with chronic lymphocytic leukemia: A single-center experience. Hematology/Oncology and Stem Cell Therapy.
Crossref
M. I. Kislova, A. A. Petrenko, M. P. Kostinov & E. A. Nikitin. (2021) Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems. Epidemiology and Vaccinal Prevention 20:3, pages 91-106.
Crossref
Malgorzata McMasters, Barbra M. Blair, Hillard M. Lazarus & Carolyn D. Alonso. (2021) Casting a wider protective net: Anti-infective vaccine strategies for patients with hematologic malignancy and blood and marrow transplantation. Blood Reviews 47, pages 100779.
Crossref
Mohammad Ammad Ud Din & Saad Jamshed. (2021) COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia: What Can We Expect?. Oncology & Haematology 17:1, pages 7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.